Dudediligence.

Alto Neuroscience, Inc

ANRONYSE · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Director or officer changeAug 27 →InsidersNo open-market buys or sales.→HoldersAlpha Wave Global 10.6%Commodore Capital 7.8%BlackRock 6.0%→Financing →PeersClosest companies: TNGX, IDYA, MPLT→

From the filings

Figures

Net income
−$84.2Mlast 12 months
Operating cash flow
−$62.3Mlast 12 months
Cash and equivalents
$243.7Mat the last balance sheet
Total debt
$16.2Mat the last balance sheet
Shares outstanding
35.1M shareson issue
Every year and quarter →